His academic interests and clinical work have focused on pulmonary and mediastinal pathology, forensic trauma, aviation pathology, and the pathology of substance-related deaths. In addition to his ...

His academic interests and clinical work have focused on pulmonary and mediastinal pathology, forensic trauma, aviation pathology, and the pathology of substance-related deaths. Dr Gary L. Collins has ...

1 Department of CardioThoracic Surgery, Gentofte University Hospital, DK-2900 Hellerup, Copenhagen, Denmark 2 Department of Surgical Gastroenterology, Gentofte University Hospital 3 Department of ...

According to the postoperative pathology reports, the lymph node clearance rate ... and histological types were not risk factors for mediastinal lymph node clearance (ypN0/N1) or intralobar lymph node ...

Department of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Pathology, University of Texas ... for the diagnosis of lymphoma in patients with ...

The abstract by Zucca et al, entitled, “Observation vs. radiotherapy in primary mediastinal B-cell lymphoma patients with complete response to standard immunochemotherapy: The IELSG37 randomized trial ...

Let's take a closer look at that reflection. A Platform for Pathology Technology, particularly social media, didn’t just reflect pathological traits. In many cases, it empowered them.

The Department of Pathology at University Hospitals Cleveland Medical Center, in collaboration with Case Western Reserve University (CWRU) School of Medicine has a long history and strong tradition of ...

Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...

Accurate staging of the mediastinal lymph nodes in resectable non–small-cell lung cancer (NSCLC) is critically important to determine the overall stage of the tumor and guide subsequent management.

Spotlight Pathology, a Daresbury-based MedTech company developing AI-powered pathology tools, has secured £425,000 from Manchester’s EHE Ventures in a funding round to help clinicians diagnose ...